Poseida Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
14.80
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
4
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.65
|
0.92
|
1.57
|
241.54%
|
|
2022-06-30
|
-0.76
|
-0.69
|
0.07
|
9.21%
|
|
2022-03-31
|
-0.66
|
-0.93
|
-0.27
|
-40.91%
|
|
2021-12-31
|
-0.35
|
0.02
|
0.37
|
105.71%
|
|
2021-09-30
|
-0.74
|
-0.68
|
0.06
|
8.11%
|
|
2021-06-30
|
-0.63
|
-0.74
|
-0.11
|
-17.46%
|
|
2021-03-31
|
-0.63
|
-0.62
|
0.01
|
1.59%
|
|
2020-12-31
|
-0.69
|
-0.58
|
0.11
|
15.94%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.70
|
|
2021-12-31
|
-2.02
|
|
2020-12-31
|
-4.93
|
|
2018-12-31
|
-0.51
|